What is Vive Organic?
Vive Organic operates at the intersection of holistic health and convenience, specializing in the production of functional wellness shots derived from high-quality organic superfoods. By leveraging a team of medical professionals to formulate products such as immunity and wellness rescue shots, the company has differentiated itself in a crowded beverage landscape. Their business model integrates direct-to-consumer subscription services with retail distribution, emphasizing sustainability and clean-label transparency. This approach has allowed Vive Organic to cultivate a loyal customer base that prioritizes preventative health and daily wellness optimization, positioning the firm as a leader in the functional beverage category.
How much funding has Vive Organic raised?
Vive Organic has raised a total of $20M across 2 funding rounds:
Series A
$7M
Series B
$13M
Series A (2018): $7M, investors not publicly disclosed
Series B (2020): $13M led by PowerPlant Ventures, Cambridge Companies, and Monogram Capital Partners
Key Investors in Vive Organic
Monogram Capital Partners
Monogram Capital Partners is a private equity firm specializing in consumer and retail companies, providing strategic guidance and operational expertise to help brands achieve category leadership.
PowerPlant Ventures
PowerPlant Ventures is a venture capital firm focused on investing in plant-based and sustainable food and beverage companies that are disrupting the traditional food system.
Cambridge Companies
Cambridge Companies is an investment firm that partners with high-growth consumer brands, offering capital and strategic support to scale operations and market presence.
What's next for Vive Organic?
With the recent influx of capital, Vive Organic is well-positioned to accelerate its operational expansion and deepen its market penetration. The strategic focus will likely shift toward optimizing supply chain efficiencies, broadening its retail footprint, and enhancing its digital subscription infrastructure. As the company transitions from its Series B phase, the emphasis will remain on maintaining product integrity while scaling production to meet the rising demand for immunity-focused health solutions. Future growth will be driven by continued innovation in superfood formulations and the potential for category expansion within the broader consumer healthcare and wellness ecosystem.
See full Vive Organic company page
